Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
34.5M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
-222K
-
Total reported value, excl. options
-
$389M
-
Value change
-
-$3.33M
-
Number of buys
-
31
-
Number of sells
-
-18
-
Price
-
$18.55
Significant Holders of ArriVent BioPharma, Inc. - Common Stock (AVBP) as of Q2 2024
63 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock as of Q2 2024.
ArriVent BioPharma, Inc. - Common Stock (AVBP) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 34.5M outstanding shares and own 60.78% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4.48M shares), ORBIMED ADVISORS LLC (3.03M shares), FMR LLC (1.95M shares), Octagon Capital Advisors LP (1.8M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.71M shares), Sofinnova Investments, Inc. (1.7M shares), Novo Holdings A/S (1.5M shares), General Catalyst Group Management, LLC (1.49M shares), BlackRock Inc. (663K shares), and VANGUARD GROUP INC (651K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.